Aurora Cannabis to participate in Israeli medical cannabis conference

Aurora Cannabis to participate in Israeli medical cannabis conference

Chief Science Officer Jonathan Page will be a keynote speaker at the prestigious event

This year, the International Medical Cannabis Conference will be held for the fourth time. It has become a highly respected gathering of scientific experts in the cannabis ecosystem and this year’s conference, dubbed CannX, is going to see participation by a number of important companies in the industry. One of these is Aurora Cannabis (TSE: ACB), which is sending its chief science officer to Israel for the event.

Jonathan Page has been tapped to be a keynote speaker at the event. He will be joined by other reputable industry leaders, including Professor Raphael Mechoulam, who presides over the conference; Tilray’s VP of patient research and access, Philippe Lucas; and Canopy Health Innovation’s director of CMC (chemistry, manufacturing and controls), Kevin Roland. There will also be participation by Professor Dedi Meiri, a dedicated cancer researcher, and others. It is billed as the perfect location to receive the “latest updates and developments across all segments of the medical cannabis field and meet the leading medical cannabis businesses and education partners to help grow your business and raise your company’s profile in the field.”

CannX will be held September 9 and 10 in Tel Aviv at the Tel Aviv Convention Center (Merkaz HaYeridim). It is put together with the assistance of Cann10, a company that provides assistance for cannabis investments, startups, research and development projects and more. Similar conferences are scheduled to be held soon in Lisbon, Portugal and Sao Paolo, Brazil, as well.

According to the event’s program, it will include topics such as, “Cannabis, psychology and emotions – the influence of different cannabis compound on our body and mind,” “Cannabis treatment as an exit strategy – substitute for opioids, alcohol and other drugs,” “The impact of cannabis-based treatment on various diseases – pre-clinical and clinical results,” “The next step in cannabis treatment: the benefits of cannabis micro-dosing,” “The medical cannabis capital market – how to assess the true value of a company?” and more.

Social Media Auto Publish Powered By :